Home » Topics » Regulatory

Regulatory
RSS

New use claimed for olanzapine

Nov. 26, 1996

Approval recommended for Elan's gel formulation of diazepam

Nov. 21, 1996

First regulatory approval for impotence treatment

Nov. 21, 1996

Otsuka discloses inhibitor of TNF-alpha production

Nov. 21, 1996

FDA approves treatment for homocystinuria

Nov. 19, 1996

FDA approves once-daily antihypertensive combination

Nov. 15, 1996

More convenient formulation of Azmacort cleared for asthma prophylaxis

Nov. 15, 1996

New MS treatment approved in Israel

Nov. 15, 1996

New formulation of Leukine approved by FDA

Nov. 15, 1996

New formulation of amifostine covered by U.S. patent

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.